title: Re: Johann S. de Bono, Matthew R. Smith, Fred Saad, et al. Subsequent Chemotherapy and Treatment Patterns After Abiraterone Acetate in Patients with Metastatic Castration-resistant Prostate Cancer: Post Hoc Analysis of COU-AA-302. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2016.06.033.
authors.affiliation: Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy; Unit of molecular therapy and pharmacogenomic, ASST Cremona, Cremona, Italy. Electronic address: giandomenicoroviello@gmail.com.
authors.forename: Giandomenico
authors.initials: G
authors.lastname: Roviello
authors.affiliation: Unit of molecular therapy and pharmacogenomic, ASST Cremona, Cremona, Italy; Department of Medical, Surgery and Health Sciences, University of Trieste, Trieste, Italy.
authors.forename: Daniele
authors.initials: D
authors.lastname: Generali
authors.affiliation: Medical Oncology Unit, University of Siena, Siena, Italy.
authors.forename: Roberto
authors.initials: R
authors.lastname: Petrioli
mesh_terms: D000069501:Abiraterone Acetate; D006801:Humans; D008297:Male; D011241:Prednisone; D064129:Prostatic Neoplasms, Castration-Resistant
chemical_list: D000069501:Abiraterone Acetate; D011241:Prednisone